Lumenis Collaborates With Gynecologists at the 2014 AAGL Global Congress to Drive Innovation for Its Minimally Invasive Solutions

VANCOUVER, BC--(Marketwired - Nov 17, 2014) -  Lumenis Ltd. (NASDAQ: LMNS), the world's largest energy-based medical company for surgical, ophthalmology and aesthetic applications, is cooperating with leading Gynecologists at the American Association of Gynecologic Laparoscopists (AAGL) Annual Meeting, which takes place November 17-21, 2014 in Vancouver, Canada. Lumenis will showcase its AcuPulse™ DUO solution for minimally invasive gynecological surgery at booth #900.

AcuPulse DUO is the only system that combines free beam and fiber technologies in a 40 watts energy transmission for a range of unique surgical solutions in Gynecology,along with a broad range of advanced CO₂ laser fibers and accessories.

• For free beam delivery, the SurgiTouch™ scanner and operating system has become an industry benchmark for precision in CO₂ laser surgery, assuring reproducible tissue-effects that can be perfectly tailored to patient anatomy.
• For fiber delivery, advanced CO₂ single or multiple use durable glass fiber with its renewable tip can be used either in robotic surgery or with specially designed GYN Laparoscopic handpieces. The high energy transmission, unparalleled durability and flexibility of the fibers reassure the tissue is managed in a very selective and dilcate mode of operation, allowing controlled and focused thermal effect.
• Handpieces Portfolio -- designated sets of rigid, malleable, GYN LAP R, and GYN LAP S -- are designed to facilitate surgeon technique preference, through a trocar cannula or the suction irrigator, for optimal maneuverability and access to the most difficult to reach areas.

"When it comes to delicate laparoscopic surgery for endometriosis, fibroids, and ovarian cysts, where preservation of fertility is often desired optimal thermal control and precision are required for the best tissue management, the Lumenis platform is the solution of my choice," said Michael D. Randell, M.D., F.A.C.O.G., of OBGYN Atlanta. "With three different power mode settings available on the Lumenis laser, I have exceptional control over cutting, ablation, and obtaining adequate hemostasis with the least amount of disturbance to adjacent tissue. Along with the red aiming beam, I can target just the tissue I want to remove. In addition, the flexibility of the laser fiber allows for better access to various anatomic areas in the pelvis. With the drop-in guide system, I can bring the advantages of laser technology to robotic surgery."

Lumenis' CO₂ laser fibers enable surgeons to access difficult-to-reach anatomy through handpieces or flexible endoscopes with high, consistent transmittance and renewable tips that allow precise surgeries to be performed with maximum efficiency.

• FiberLase™ CO₂ fiber is a single-use, high performance fiber with multiple handpiece configurations that expand the range of procedures surgeons can perform.
• FiberLase™ ENDURE™ CO₂ Fiber is a multi-use durable fiber that balances dependability, quality, and flexibility with cost effectiveness.
• FiberLase™ STC can be used with surgeons' existing laser consoles for smarter tissue management.
• The FiberLase™ Drop-in Guide enhances robotic fiber utilization with superior precision and better thermal control.

"At Lumenis, we believe that providing women more options for their gynecological health is giving them the freedom of choosing the best option," said Tzipi Ozer-Armon, CEO of Lumenis. "This can only be achieved by providing gynecological surgeons with broad, versatile tailored solutions. We built our leading portfolio of laser systems, fibers and accessories on the premise that strong physician collaboration is important to energize innovation and leads to better patient care. We look forward to continuing our collaboration with the gynecology community on new solutions, services and educational programs to improve patient outcomes and enhance quality of life for women across the globe."

About Lumenis
Lumenis (NASDAQ: LMNS) is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For nearly 50 years, Lumenis' ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold-standards. Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods. For more information visit: www.lumenis.com